Concepedia

Publication | Open Access

Isoagglutinin Reduction in Human Immunoglobulin Products by Donor Screening

DOIFull Paper Access

38

Citations

7

References

2014

Year

Brigitte Siani, Katharina Willimann, Sandra Wymann, A. Adriano Marques, Eleonora Widmer
Biologics in Therapy

Abstract

Reduction of anti-A/B isoagglutinin titers in IVIG products on an industrial scale is feasible through implementation of anti-A donor screening, which may reduce the risk of hemolysis following IVIG therapy.

References

YearCitations

Page 1